Context Therapeutics Inc.
CNTXAs of the close on Sep 25, 2026
Price
$0.35
Market cap
$31.8M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$0.48
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Context Therapeutics Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Squadron Capital Management LLC | 2026-03-31 | 1,100,000 | Not shown | SEC filing |
| Deep Track Capital, LP | 2026-03-31 | 7,419,355 | Not shown | SEC filing |
| HRT FINANCIAL LP | 2026-03-31 | 104,973 | Not shown | SEC filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2026-03-31 | 1,000,000 | Not shown | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 1,424,374 | Not shown | SEC filing |
| Sanctuary Advisors, LLC | 2026-03-31 | 19,316 | Not shown | SEC filing |
| Woodline Partners LP | 2026-03-31 | 250,088 | Not shown | SEC filing |
| Pathstone Holdings, LLC | 2026-03-31 | 110,244 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 436,931 | Not shown | SEC filing |
| TCG Crossover Management, LLC | 2026-03-31 | 2,682,696 | Not shown | SEC filing |
| FRANKLIN RESOURCES INC | 2026-03-31 | 3,803,338 | Not shown | SEC filing |
| Avidity Partners Management LP | 2026-03-31 | 4,998,267 | Not shown | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 10,500 | Not shown | SEC filing |
| Corient Private Wealth LLC | 2026-03-31 | 26,534 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 78 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 233,507 | Not shown | SEC filing |
| MPM BIOIMPACT LLC | 2026-03-31 | 10,679,391 | Not shown | SEC filing |
| Legacy Capital Wealth Partners, LLC | 2026-03-31 | 10,315 | Not shown | SEC filing |
| Soleus Capital Management, L.P. | 2026-03-31 | 6,963,141 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 182,999 | Not shown | SEC filing |
- Each value is checked against Context Therapeutics Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 21,967 shares reported 2025-09-30; 1,093,894 shares reported 2026-03-31.
- Qube Research & Technologies Ltd: 82,111 shares reported 2025-09-30; 11,398 shares reported 2026-03-31.
- Point72 Asset Management, L.P.: 52,701 shares reported 2025-12-31; 57,231 shares reported 2026-03-31.
- CITADEL ADVISORS LLC: 34,380 shares reported 2025-12-31; 140,017 shares reported 2026-03-31.
- BANK OF AMERICA CORP /DE/: 933 shares reported 2025-12-31; 114,888 shares reported 2026-03-31.
- Nextech Invest, Ltd.: 7,419,355 shares reported 2025-12-31; 7,419,355 shares reported 2026-03-31.
- Virtu Financial LLC: 28,921 shares reported 2025-12-31; 23,100 shares reported 2026-03-31.
- HighTower Advisors, LLC: 125,852 shares reported 2025-12-31; 126,152 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 608,462 shares reported 2025-12-31; 603,767 shares reported 2026-03-31.
- GREAT POINT PARTNERS LLC: 4,683,711 shares reported 2025-12-31; 2,238,496 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 84,281 shares reported 2025-12-31; 103,256 shares reported 2026-03-31.
- CITIGROUP INC: 1,348 shares reported 2025-12-31; 12,182 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
24 filers have only one report here.
Independent insiders buying near the same time
- 2025-06-06–2025-06-09: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-12-09–2022-12-16: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-08-16–2022-08-19: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-09 | Lehr Martin A. · Chief Executive Officer | Common Stock | P — Open market or private purchase | +100,000 | 0.70 | SEC filing |
| 2025-06-06 | Levit Alex C. · Chief Legal Officer, Corp. Sec | Common Stock | P — Open market or private purchase | +20,000 | 0.58 | SEC filing |
| 2025-06-06 | Minai-Azary Jennifer Lynn · Chief Financial Officer | Common Stock | P — Open market or private purchase | +40,010 | 0.64 | SEC filing |
| 2023-02-21 | Lehr Martin A. · Chief Executive Officer | Common Stock | P — Open market or private purchase | +5,823 | 0.84 | SEC filing |
| 2023-02-13 | Lehr Martin A. · Chief Executive Officer | Common Stock | P — Open market or private purchase | +5,606 | 0.87 | SEC filing |
| 2023-02-06 | Lehr Martin A. · Chief Executive Officer | Common Stock | P — Open market or private purchase | +5,040 | 0.97 | SEC filing |
| 2023-01-30 | Lehr Martin A. · Chief Executive Officer | Common Stock | P — Open market or private purchase | +7,027 | 0.70 | SEC filing |
| 2023-01-23 | Lehr Martin A. · Chief Executive Officer | Common Stock | P — Open market or private purchase | +6,839 | 0.72 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-24 | Walker Luke Nathaniel · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +45,000 | SEC filing |
| 2026-06-24 | Smith Karen L. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +45,000 | SEC filing |
| 2026-06-24 | Kantoff Philip W. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +45,000 | SEC filing |
| 2026-06-24 | Pasternak Andy · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +45,000 | SEC filing |
| 2026-06-24 | West Linda · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +45,000 | SEC filing |
| 2026-06-24 | Stacey Jennifer Evans · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +45,000 | SEC filing |
| 2026-02-19 | Chagin Karen Deborah · Chief Medical Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +290,000 | SEC filing |
| 2026-02-19 | Lehr Martin A. · Chief Executive Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +815,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.